123 related articles for article (PubMed ID: 36332846)
1. Hormonal Contraceptive Use and Risk of Depression Among Young Women With Attention-Deficit/Hyperactivity Disorder.
Lundin C; Wikman A; Wikman P; Kallner HK; Sundström-Poromaa I; Skoglund C
J Am Acad Child Adolesc Psychiatry; 2023 Jun; 62(6):665-674. PubMed ID: 36332846
[TBL] [Abstract][Full Text] [Related]
2. Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden.
Skoglund C; Kopp Kallner H; Skalkidou A; Wikström AK; Lundin C; Hesselman S; Wikman A; Sundström Poromaa I
JAMA Netw Open; 2019 Oct; 2(10):e1912463. PubMed ID: 31577361
[TBL] [Abstract][Full Text] [Related]
3. Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15-34 years of age: A nationwide register-based study.
Niemeyer Hultstrand J; Gemzell-Danielsson K; Kallner HK; Lindman H; Wikman P; Sundström-Poromaa I
Lancet Reg Health Eur; 2022 Oct; 21():100470. PubMed ID: 35923559
[TBL] [Abstract][Full Text] [Related]
4. There is no association between combined oral hormonal contraceptives and depression: a Swedish register-based cohort study.
Lundin C; Wikman A; Lampa E; Bixo M; Gemzell-Danielsson K; Wikman P; Ljung R; Sundström Poromaa I
BJOG; 2022 May; 129(6):917-925. PubMed ID: 34837324
[TBL] [Abstract][Full Text] [Related]
5. Maternal use of hormonal contraception and risk of childhood ADHD: a nationwide population-based cohort study.
Hemmingsen CH; Kjaer SK; Jezek AH; Verhulst FC; Pagsberg AK; Kamper-Jørgensen M; Mørch LS; Hargreave M
Eur J Epidemiol; 2020 Sep; 35(9):795-805. PubMed ID: 32968938
[TBL] [Abstract][Full Text] [Related]
6. Association of Perinatal and Childhood Ischemic Stroke With Attention-Deficit/Hyperactivity Disorder.
Bolk J; Simatou E; Söderling J; Thorell LB; Persson M; Sundelin H
JAMA Netw Open; 2022 Apr; 5(4):e228884. PubMed ID: 35471571
[TBL] [Abstract][Full Text] [Related]
7. Association of Hormonal Contraception With Depression.
Skovlund CW; Mørch LS; Kessing LV; Lidegaard Ø
JAMA Psychiatry; 2016 Nov; 73(11):1154-1162. PubMed ID: 27680324
[TBL] [Abstract][Full Text] [Related]
8. Contraception for women with diabetes: an update.
Skouby SO; Mølsted-Pedersen L; Petersen KR
Baillieres Clin Obstet Gynaecol; 1991 Jun; 5(2):493-503. PubMed ID: 1954724
[TBL] [Abstract][Full Text] [Related]
9. Knowledge, challenges, and standard of care of young women with ADHD at Swedish youth clinics.
Klint Carlander AK; Thorsell M; Demetry Y; Nikodell S; Kopp Kallner H; Skoglund C
Sex Reprod Healthc; 2022 Jun; 32():100727. PubMed ID: 35461165
[TBL] [Abstract][Full Text] [Related]
10. Association of Hormonal Contraception With Suicide Attempts and Suicides.
Skovlund CW; Mørch LS; Kessing LV; Lange T; Lidegaard Ø
Am J Psychiatry; 2018 Apr; 175(4):336-342. PubMed ID: 29145752
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children.
Boukhris T; Sheehy O; Bérard A
Paediatr Perinat Epidemiol; 2017 Jul; 31(4):363-373. PubMed ID: 28640459
[TBL] [Abstract][Full Text] [Related]
12. Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study.
Chang Z; D'Onofrio BM; Quinn PD; Lichtenstein P; Larsson H
Biol Psychiatry; 2016 Dec; 80(12):916-922. PubMed ID: 27086545
[TBL] [Abstract][Full Text] [Related]
13. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception.
Mack N; Crawford TJ; Guise JM; Chen M; Grey TW; Feldblum PJ; Stockton LL; Gallo MF
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004317. PubMed ID: 31013349
[TBL] [Abstract][Full Text] [Related]
14. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
[TBL] [Abstract][Full Text] [Related]
15. Perinatal Outcomes of Women Diagnosed with Attention-Deficit/Hyperactivity Disorder: An Australian Population-Based Cohort Study.
Poulton AS; Armstrong B; Nanan RK
CNS Drugs; 2018 Apr; 32(4):377-386. PubMed ID: 29557079
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.
Lemelin M; Boukhris T; Zhao JP; Sheehy O; Bérard A
Pharmacol Res Perspect; 2021 May; 9(3):e00781. PubMed ID: 34003597
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: A pharmacoepidemiological study on 800 000 Swedish women.
Zettermark S; Perez Vicente R; Merlo J
PLoS One; 2018; 13(3):e0194773. PubMed ID: 29566064
[TBL] [Abstract][Full Text] [Related]
18. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
[TBL] [Abstract][Full Text] [Related]
20. Alcohol Intake in Early Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Children Up to 19 Years of Age: A Cohort Study.
Weile LKK; Wu C; Hegaard HK; Kesmodel US; Henriksen TB; Nohr EA
Alcohol Clin Exp Res; 2020 Jan; 44(1):168-177. PubMed ID: 31742728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
